third percentile for age, head circumference below first percentile, deep-seated eyes, microcephaly, large ears, high arched palate, micrognathia, and horizontal nystagmus [ Figure 1 ]. Cutaneous examination revealed a well-defined area of erythema over central face with desquamation and few hyperpigmented macules over malar area [Figures 2 and 3]. Ocular examination showed hazy cornea, stromal opacities, optic disc pallor, and subpolar cataract. Central nervous system examination revealed low intelligence with normal motor and sensory function. Systemic examination revealed hepatosplenomegaly. Blood counts, renal function tests, liver function tests, serum electrolytes, calcium and phosphate levels were normal. Ultrasonography of abdomen showed hepatosplenomegaly. Cranial computed tomography showed calcifications in bilateral cerebral hemispheres,
INTRODUCTION
C ockayne syndrome (CS) is a very rare genetic degenerative disease with cutaneous, ocular, neurologic, and somatic abnormalities inherited in an autosomal recessive pattern. [1] This entity was first described by Cockayne in 1936; [2] 180 patients have been reported until 2010. [3] It spans a phenotypic spectrum that includes classic (CS-I), rare severe form with symptoms present from birth (CS-II) and late onset milder form (CS-III). [4] We report an infant with this syndrome with neonatal onset (CS-II).
CASE REPORT
An 11-month-old male infant born of a first degree consanguineous marriage presented with a history of erythematous rash over central face on exposure to sunlight followed by peeling of skin since 3 rd week of life. Patient had a history of failure to thrive since 5 months of age and delayed milestones. Physical examination revealed a proportionately short statured infant having both weight and height lying below white matter, and basal ganglia with diffuse cerebral atrophy [ Figure 4 ]. Magnetic resonance imaging of the brain showed atrophy of cerebrum and brainstem with hypomyelination. Auditory brainstem evoked response testing revealed severe bilateral sensorineural hearing impairment. Based on the above findings, a diagnosis of CS-II was made. Counseling was done, and photoprotection was advised.
DISCUSSION
CS is an inherited syndrome characterized by profound growth retardation, microcephaly, neurodevelopmental impairment, photosensitive skin eruption, premature skin aging, disproportionate large hands, feet and ears, ocular defects, and extreme demyelination. This syndrome has been described in children from every race and affects males and females with almost equal frequency. Cultured fibroblasts from affected patients are hypersensitive to ultraviolet light-induced inhibition of growth and colony forming abilities with a defective subpathway of nucleotide excision repair process. [3] Mutation in genes ERCC8 and ERCC6 coding for protein in transcription-coupled repair is thought to be responsible for Cockayne phenotype in the majority of cases. [5] The clinical symptoms of the multisystem disorder CS are quite heterogenous and can vary considerably in their severity. Although very early onset has been reported in a significant minority of cases, like ours, the child usually appears normal for the 1 st year, when facial erythema in the butterfly distribution develops after exposure to sunlight without excess pigmentary abnormalities. There is a marked loss of subcutaneous fat resulting in a wizened appearance with typical "bird-headed" facies, prominent "mickey mouse" ears, sparse dry hair, and thin nose. Many patients exhibit a characteristic stooped appearance with kyphoscoliosis and flexion deformities of hips, knees, and ankles. Ocular findings include pigmentary retinal degeneration with a characteristic "salt and pepper" appearance of retina, cataracts, optic nerve atrophy, optic disc pallor, iris hypoplasia, and microphthalmus. Neurological abnormalities include deafness, peripheral neuropathy, normal pressure hydrocephalus, and microcephaly. Intellectual deterioration may be nonunifrom with some preserved better than others. Dental caries, renal abnormalities with decreased creatinine clearance, hypertension, and retarded reproductive development are reported in few CS patients.
Nance and Berry [6] have proposed diagnostic criteria for CS including growth failure, neurodevelopmental and neurological dysfunction, cutaneous photosensitivity, progressive ocular abnormalities, sensorineural hearing impairment, dental caries, and a characteristic wizened facial appearance. A diagnosis of classical CS (CS-I) which includes the majority of patients is applied to children who fulfill the diagnostic criteria beginning after the 1 st year of life. CS-II, a severe form of CS with early onset and rapid progression, has been reported in over twenty patients. They exhibit intrauterine growth retardation, poor postnatal growth, severe and more rapidly progressive neurological impairment. In 30% of cases, structural abnormalities of the eyes and early or congenital cataracts are present. This subset is important prognostically because death usually occurs by the age of 6 or 7 years in children with CS-II phenotype. Patients with classical CS can survive into adolescence and early adulthood. A third, milder form (CS-III) characterized by late onset and slow progression of signs and symptoms is also reported. Such patients exhibit some CS features but lack one of the hallmarks of abnormal growth and mental retardation. [7] Diagnosis is usually made based on characteristic clinical features, but definitive diagnosis is achieved by laboratory investigations such as cytogenic, biochemical, and molecular methods. Although dwarfism and premature senile appearance are characteristic of progeria, it lacks photosensitivity, ocular defects, and disproportionate large extremities. Poikiloderma and involvement of buttocks and extremities delineate Rothmund-Thomson syndrome from CS. In Blooms syndrome, erythema of face and hands is associated with growth retardation, but neurological development and intelligence are normal. CS is distinguished from xeroderma pigmentosum by the unusual facies, demyelination with delayed nerve conduction velocity, and lack of cutaneous malignancy.
Recently, Wilson et al. suggested that the presence of early cataracts as the most valuable factor that determines prognosis based on their CS Natural History Study in 102 individuals. [8] Treatment for CS is generally supportive and includes photoprotection, physiotherapy, and optimizing nutrition. Genetic counseling should be provided to the parents as the recurrence risk for future pregnancies is 25%. Prenatal diagnosis is now possible for the condition by fast growing chorionic villous cultures and amniotic fluid cultures based on RNA synthesis recovery test and should be considered in couples at high risk. [9] 
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